Despite the many uncertainties that the omicron variant brings, one thing is clear: our already overwhelmed health care workforce will be put to the test yet again. How can health care leaders prepare their staff? Advisory Board’s Carol Boston-Fleischhauer and Junhong Peng unveil four key strategies.
A federal judge on Tuesday issued a nationwide injunction, blocking CMS' mandate requiring workers in most health care settings participating in Medicare and Medicaid to be fully vaccinated against Covid-19 by Jan. 4, arguing CMS doesn't have the authority to enact such a mandate.
While recent news of the omicron variant has captured the world's attention, the delta variant continues to fuel new surges in cases and hospitalizations in many states across the United States—but delays in testing and data reporting over the holidays may mask the true severity of this latest surge.
An FDA advisory panel on Tuesday recommended Merck's antiviral pill, molnupiravir, for emergency use, and the agency is also reviewing a separate antiviral pill developed by Pfizer. But experts say that while Americans may soon have access to these treatments, the success of the drugs will largely depend on access to timely, affordable testing. Advisory Board’s Pamela Divack dives into four of the most important considerations right now.
Amid rising Covid-19 cases worldwide, the demand for N95 masks has once again skyrocketed, Andrew Jacobs writes for the New York Times—but many who try to purchase these masks online or from big box retailers have unknowingly been sold counterfeit or defective alternatives that have not been approved by U.S. regulators.
New York City health officials have reinstated an indoor mask advisory for all residents, regardless of vaccination status—in today's bite-sized hospital and health industry news from Minnesota, New York, and Ohio.
Print All Daily Briefing Article from
Have a Question?
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.